Sigyn Therapeutics, Inc. (SIGY): Net Income
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
-$3.34M
Year ended 2024-12-31
-$3.22M
Trailing 12 months to 2025-09-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | -$3.34M | n/m | 2025-04-15, From 2024-01-01 |
| 2023-12-31 | -$4.15M | n/m | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | -$2.93M | n/m | 2024-02-20, From 2022-01-01 |
| 2021-12-31 | -$3.00M | n/m | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$1.26M | n/m | 2022-03-21, From 2020-01-01 |
| 2019-12-31 | -$3.07M | n/m | 2020-03-30, From 2019-01-01 |
| 2018-12-31 | -$2.62M | n/m | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | -$4.25M | n/a | 2019-04-01, From 2017-01-01 |
| No annual figure between 2015-12-31 and 2017-12-31. | |||
| 2015-12-31 | -$2.69M | n/m | 2016-03-30, From 2015-01-01 |
| 2014-12-31 | -$387.5K | n/a | 2016-03-30, From 2014-01-01 |